On the Road to NIH SBIR/STTR Grant Success-

Submission Strategies for Phase 1/Phase 2  SBIR Applications

 

SBIR applications to the NIH were initially constrained to submission of a Phase 1 application, and then a subsequent Phase 2 application. The agency has additional application options so companies can now tailor a strategy that best fits their research goals and financial circumstances. Importantly, these can include an awareness of time constraints for optimal marketing opportunities for a company’s technology due to patent timelines. Here are some aspects to consider when applying for SBIR/STTR funds.

 

What are the Differences Between Phase 1 and Phase 2 SBIR Applications?

 

Phase 1 SBIR applications are for early-stage research to demonstrate proof of concept and feasibility of new and risky technology, and generally span 6-12 months. The budget is limited to $275,766 (includes direct costs, indirect costs, and fee), although some Institutes award greater amounts for selected topics. Companies should request a waiver from the Institute to exceed this budget cap well in advance of the application deadline.

 

Phase 2 SBIR applications are to further develop technology described in a Phase 1 application and have an expanded timeline of ~2 years along with a larger budget limit of $1,838,436 (includes direct costs, indirect costs and fee). As with Phase 1 applications, this budget cap can be exceeded for certain topics. All Phase 2 applications (including Fast Track and Direct to Phase 2) have a detailed Commercialization Plan (12 page limit) describing business aspects of the company and how the technology will be marketed.

 

There are several options to access Phase 1 and Phase 2 funding:

 

Sequential Submission

A company can submit a Phase 1 SBIR application, and then if the Specific Aims are successfully met, apply for additional funds through a Phase 2 application. The subsequent Phase 2 SBIR application must be submitted within the first 6 submission deadlines after the Phase 1 budget ends.

This approach is suited to emerging companies with limited data to support a new, unproven technology. Through the Phase 1 funds, it provides a chance to demonstrate feasibility of the technology and an understanding of the potential market, which can provide the basis for a Phase 2 application. Due to the grant submission and review process, companies will need to plan for a funding gap of at least six months between the end of the Phase 1 budget and the beginning of a Phase 2 award.

Fast Track

The Phase 1/Phase 2 SBIR applications are combined in this submission and reviewed at the same time. The Phase 1 aspect needs to have clear, measurable milestones for advancing to Phase 2.

 

This approach is more suited to companies that have a high likelihood of success with proposed work under the Phase 1 aspect of the application. A company can save time as the funding gap after completing Phase 1 is shortened compared with a traditional sequential Phase 1/Phase 2 application.

 

Direct to Phase 2 SBIR Applications

A company can arrange for Phase 1 work with outside funding, and then apply directly with a Phase 2 submission. The application needs to describe the equivalent of Phase 1 results in sufficient detail to demonstrate proof of concept of a technology. Note that this option is not available under the STTR program and is not offered by the CDC and FDA.

This approach is suited to companies with a more developed technology and a clear understanding of market potential.

How to Choose?

The optimal submission strategy for SBIR applications will depend on a company’s development stage with regard to their technology, level of understanding about market potential to complete a Commercialization Plan as well as the ability to attract other sources of investment to span funding gaps.

 

Useful websites

 

Basics of SBIR/STTR grants

https://seed.nih.gov/small-business-funding/small-business-program-basics/understanding-sbir-sttr

 

Topics allowed for NIH SBIR/STTR budget waivers

https://seed.nih.gov/sites/default/files/NIH_topics_for_Budget_Waivers.pdf

 

Review guidelines for NIH SBIR/STTR applications

https://grants.nih.gov/grants/policy/review-guidelines/R41-R42-R43-R44-guide-for-reviewers.htm

 

NIH SBIR Grant Reviewer

Learn more about NIH SBIR Grant Writer Dr. Marcy

 

Grant Proposals – The Process

Facebooktwitterlinkedinmail
0 Comments

Leave a reply

©2022 ScienceDocs Inc.

CONTACT US

We're not around right now. But you can send us an email and we'll get back to you, asap.

Sending

Log in with your credentials

Forgot your details?